You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FGFR1-3 Mutation or fusion/rearrangements

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life

Active, not recruiting
  • FGFR1 Gene Amplification
  • +18 more
  • Scottsdale, Arizona
  • +5 more
Oct 18, 2022

Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

Recruiting
  • Cholangiocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +16 more
Jan 3, 2023

Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

Not yet recruiting
  • Recurrent ALK Positive Large B-Cell Lymphoma
  • +28 more
  • Biospecimen Collection
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 17, 2022

Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements Trial in Worldwide (TAS-120, Cisplatin/Gemcitabine)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Rearrangements
  • Albuquerque, New Mexico
  • +100 more
Feb 1, 2023

Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)

Active, not recruiting
  • Advanced or Metastatic Solid Tumor
  • +2 more
  • Gilbert, Arizona
  • +60 more
Oct 20, 2022

Solid Tumor Trial in Worldwide (Debio 1347)

Terminated
  • Solid Tumor
  • Debio 1347
  • Scottsdale, Arizona
  • +104 more
Mar 30, 2022

NTRK Family Gene Mutation Trial in Germany

Recruiting
  • NTRK Family Gene Mutation
    • Berlin, Germany
    • +22 more
    Jan 18, 2023

    Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

    Not yet recruiting
    • Advanced Solid Tumor
    • +2 more
    • Palo Alto, California
    • +9 more
    Aug 2, 2022

    Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Combined Hepatocellular and Cholangiocarcinoma
    • Phoenix, Arizona
    • +40 more
    Mar 7, 2022

    Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

    Recruiting
    • Glioblastoma
    • Adult-type Diffuse Gliomas
    • Beverly Hills, California
    • +83 more
    Jul 25, 2022

    Cholangiocarcinoma Trial in China, Japan (E7090)

    Active, not recruiting
    • Cholangiocarcinoma
    • Bengbu, Anhui, China
    • +55 more
    Jan 24, 2023

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)

    Not yet recruiting
    • Locally Advanced Unresectable Gastric Cancer
    • Guangzhou, Guangdong, China
      Cancer center of SunYat-sen University
    Aug 11, 2023

    Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)

    Not yet recruiting
    • Advanced Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Sep 30, 2022

    Advanced Cholangiocarcinoma, FGFR2 Gene Mutation Trial in Worldwide (BGJ398, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Advanced Cholangiocarcinoma
    • FGFR2 Gene Mutation
    • Gilbert, Arizona
    • +115 more
    Oct 17, 2022

    NSCLC Trial in Suzhou (Pemigatinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Suzhou, China
      The First Affiliated Hospital of Soochow University
    Jan 14, 2022

    Either EML4-ALK Gene Rearrangements or T790M EGFR Mutation in

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Hollywood, Florida
      • +1 more
      Sep 29, 2021

      NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)

      Recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • Los Angeles, California
      • +41 more
      Jun 27, 2022

      Advanced NSCLC Trial in Xiamen (Pemigatinib)

      Recruiting
      • Advanced Non-Small Cell Lung Cancer
      • Xiamen, Fujian, China
        the First Affiliated Hospital of Xiamen University
      Mar 10, 2022

      Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

      Not yet recruiting
      • Recurrent Glioblastoma, IDH-Wildtype
      • +2 more
      • Biospecimen Collection
      • +2 more
      • (no location specified)
      May 13, 2023

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +44 more
      • Biopsy
      • +23 more
      • Birmingham, Alabama
      • +166 more
      Feb 2, 2023

      Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

      Recruiting
      • Intrahepatic Cholangiocarcinoma
      • Bad Saarow, Germany
        HELIOS KLinikum Bad Saarow
      Jun 2, 2022

      Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

      Recruiting
      • Bladder Cancer
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Aug 22, 2022

      Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

      Recruiting
      • Ewing Sarcoma
      • +2 more
      • Peptide vaccine IPX
      • Frankfurt am Main, Germany
      • +2 more
      Oct 18, 2023